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Nutraceuticals from natural sources have shown potential new leads in functional food products. Despite a broad
range of health-promoting effects, these compounds are easily oxidized and unstable, making their utilization as
nutraceutical ingredients limited. In this study, the encapsulated stingless bees' propolis in liposome was prepared
using soy phosphatidylcholine and cholesterol by thin-film hydration technique. Three different formulations of
phosphatidylcholine composition and cholesterol prepared by weight ratio was conducted to extract high propolis
encapsulation. Physicochemical changes in the result of the encapsulation process are briefly discussed using
scanning electron microscopy and Fourier Transform Infrared Spectroscopy. A dynamic light-scattering instru-
ment was used to measure the hydrodynamic diameter, polydispersity index, and zeta potential. The increment of
the liposomal size was observed when the concentration of extract loaded increased. In comparing three for-
mulations, F2 (8:1 w/w) presented the best formulation as it yielded small nanoparticles of 275.9 nm with high
encapsulation efficiency (66.9%). F1 (6:1 w/w) formed large particles of liposomes with 422.8 nm, while F3 (10:1
w/w) showed low encapsulation efficiency with (by) 38.7%. The liposome encapsulation will provide an effective
nanocarrier system to protect and deliver the flavonoids extracted from stingless bees' propolis.1. Introduction
Propolis is a natural product from bees' hives that has a resinous
consistency and is highly variable in terms of physical appearance and
color, depending on the botanical, geographical origin, and time of its
collection [1, 2]. In general, propolis is composed of 50–60% resins,
30–40% waxes and fatty acids, 5–10% essential oils, 5% pollens and
microelements [3]. Propolis contains minerals and phenolic compounds
such as flavonoids aglycones, phenolic acids and their esters, phenolic
aldehydes, alcohols, ketones, steroids, terpenes, sugars, and amino
acids [4, 5]. Among them, flavonoid, together with phenolic com-
pounds, are reported to contribute greatly to biological and pharma-
cological activities compared to the other propolis constituents [6], and
it is proposed as a good marker of propolis quality [7]. The nutritionist
has highlighted dietary flavonoids as a novel bioactive medicinal agent
with various therapeutic properties for human well-being, such as
antioxidant, anti-inflammatory, anticancer, and antimicrobial activities
[8, 9].orm 2 February 2021; Accepted 2
vier Ltd. This is an open access arHowever, in Malaysia, there is a lack of experimental research on the
nutraceutical of stingless bees propolis, locally known as 'lebah kelulut'
[10]. Untapped propolis produced by stingless bees are usually regarded
as waste by traditional beekeepers in Malaysia. Previous nutraceutical
experiments are more likely to rely on the propolis of honey bees than on
stingless bees. A substantial gap in research publications on stingless bee
products has been identified relative to the common honey bee products
that are well-studied. In our previous study, it was found that sticky
propolis produced byHeterotrigona itama (H. Itama) stingless bees' species
showed a higher composition of TFC (91%) and TPC (49%) compared to
the hard propolis, which resulted in the highest antioxidant activities
compared with the other nine species of stingless bees in the same origin
which was 85% of DPPH degradation [11]. Based on this finding, prop-
olis from stingless bees of H. Itama species is chosen to be extracted for
liposome encapsulation.
Flavonoid is a ubiquitously dispersed group of bioactive compounds
in the plant kingdom, including the propolis. The flavonoid, one of the
most potent compounds, has limited its stability and bioavailability [12].6 March 2021
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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administration, as it is susceptible to oxygen, sun, heat, and water [13,
14]. As a result, these factors reduce the shelf life of food items. Besides,
the flavonoid is vulnerable to low bioavailability, which requires accel-
erated body clearing, low aqueous solubility, and slow oral absorption
[15]. These disadvantages would result in a lack of potency of bioactive
compounds and decreased medicinal benefits. Therefore, attempts to
increase bioactive compounds' durability and bioavailability have
continuously been pursued to address these constraints.
Nanotechnology is an adequate tool to obtain low bioavailability of
nutraceutical delivery system [16, 17]. One of the new technologies
designed to avoid bioactive compounds' degradation while retaining its
functional characteristics, is encapsulation. Encapsulation allows the
defence of a wide variety of bioactive substances by embedding them in a
protective carrier matrix. Not just for safety, nanotechnology de-
velopments will increase the bioavailability of bioactive substances by
reducing the scale of nano-size particles to prevent the risk of accelerated
clearance in the body [10]. In this respect, liposomes could be a viable
encapsulation mechanism that could solve the issues on bioactive fla-
vonoids and phenolic compounds as mentioned above. The liposome is a
colloidal, vesicular structure dependent on bilayer phospholipids [18],
and can entrap bioactive compounds in its protective matrix.
This research describes an approach used to protect flavonoids pre-
sent in propolis, through its encapsulation in liposomes. A carefully
engineered nanocarrier may significantly accelerate nutraceutical dis-
tribution, and expand the spectrum of potential therapeutic and medic-
inal applications. By integrating the characteristics of liposomes, a high
encapsulation performance and loading capability with enhanced phys-
ical stability can be achieved in the manufacturing of nutraceutical car-
riers. The actual challenge lies in the formulation and preparation
condition to obtain the required physicochemical characteristics, for a
high encapsulation efficiency of the compound's desired target. However,
methods for synthesizing liposomes are still under research development
to enhance the collective interrelated effects of liposomes' physico-
chemical stabilities. In this context, soy phosphatidylcholine's effect on
cholesterol ratio and concentration of propolis extract loaded, was
studied to obtain the best liposome formulation for a high propolis
extract capture. This study found the characterization and assessment of
three liposomal formulations, particularly liposomes' encapsulation per-
formance. The liposome formulations produced are compared to their
performance with average scale reference values, polydispersity index,
zeta potential, and encapsulation efficiency.
2. Material and methods
2.1. Material
Soy lecithin L-α-phosphatidylcholine from soybean with 99% (TLC)
in lyophilized powder and phosphate buffer saline (PBS) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Aluminium chloride, acetone,
chloroform, and methanol from Merck (Darmstadt, Germany). The quer-
cetin used is HPLC grade (purity 95%), and cholesterol obtained from
sheep's wool (purity 99%). All the solvents used are analytical grade.2.2. Preparation of stingless bees' propolis extract
The propolis sample was collected from stingless bees' colonies of
Heterotrigona itama (H. Itama) stingless bees' species located in a rubberTable 1. Formulation for liposome suspension at different weight ratio.





smallholding plantation, in Kuala Nerus District, Terengganu, Malaysia.
The dry sample of propolis was ground and soaked in acetone overnight
at room temperature. The sample was percolated gradually for its filtrate
and the remaining residue was extracted with 70% methanol. This step
was repeated until the filtrate became colorless. The methanol was
removed in a rotary evaporator at 45 C, providing the dry methanolic
extract of propolis. The extract was kept in a desiccator for further drying
before being preserved at 4 C before usage.
2.3. Preparation of propolis extract-loaded liposomes (PEL)
A thin-film hydration technique was used to synthesize PEL [19]. The
compositions of phosphatidylcholine and cholesterol were prepared by
weight ratio (8:1, 6:1, and 10:1 w/w). These formulations were prepared
as in Table 1. The phosphatidylcholine, cholesterol, and propolis extract
were mixed in 10 ml of methanol: chloroform (1:1 v/v) solvent. The
solvent was then evaporated by a rotary evaporator with a temperature
setting condition at 45 C. Finally, a dry lipid film formed in the round
bottom flask will be dissolved using 10 ml PBS solution. This liposomal
suspension was stirred continuously at 40 C, above its phase transition
temperature (Tc) for 30 min. Subsequently, the liposome suspension was
sonicated using a QSonica (Q700, USA) ultrasonicator, with an ampli-
tude of 40% and a comprehensive treatment of 25 min. The flask was
plunged into a cold-water bath to prevent the raising of temperature of
samples. A pulsed duty cycle was fixed for all treatments with 8s on and
2s off. After preparation, the liposome suspension was centrifuged
(15000 rpm, 4 C) for 30 min. The solvent containing the free unen-
trapped extract in the suspended stage was separated. Then, the extracted
liposomes were cleaned using 2 ml PBS solution, recentrifuged and
resuspended, to obtain 2 ml of liposome suspension before being ho-
mogenized [20].
2.4. Physicochemical characterization
The surface characteristic of liposomes observed using scanning
electron microscopy (SEM) (JEOL 6360 LA, Tokyo, Japan). The freeze-
dried PEL samples were mounted onto adhesive-taped stubs and
sputter coated with gold film by an automated coater (JFC 11600), to
prevent any charging up to the surface by the electron beam. A dynamic
light-scattering instrument (Zetasizer ZS, Malvern Instruments, Worces-
tershire, UK) was used to quantify the hydrodynamic diameter (Z-
average), polydispersity index (PDI), and zeta potential. The liposome
suspensions were diluted with distilled water to a 3.0% v/v to avoid
multiple scattering effects. The samples were then transferred into an
electrophoresis cuvette and repeated for triplicate. The spectra of PEL
were analyzed using a spectrophotometer (UV-18000 Shimadzu, Kyoto,
Japan). Samples were measured in a rectangular quartz cuvette with 1
cm path length at 25 C. Fourier Transform Infrared Spectroscopy (FT-IR)
analysis was used for the chemical composition analysis using an FT-IR
spectrometer (Spectrum 100 PerkinElmer, Boston, USA). The sample
was deposited in spectroscopic grade potassium bromide (KBr) disks.
2.5. Performance assessment of propolis extract-loaded liposome
The evaluation of the encapsulation and loading efficiency of the li-
posomes was done using ultracentrifugation method [21]. The encap-
sulation efficiency is evaluated by taking the centrifuged liposome's




Figure 1. Scanning electron microscopy images of free liposomes (FL) (a) and propolis extract-loaded liposomes (PEL) (b) with magnification of x 10,000 (scale 1 μm).
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as quercetin equivalence (QE) in propolis extract weight. A calibration
curve of Absorbance (420 nm) versusQuercetin (μg/mL) in methanol was
constructed and used to determine the total flavonoids content. The
encapsulation efficiency and loading were measured as a percentage of
flavonoids entrapped in the liposomes by means of Eqs. (1) and (2) used
by Wallace et al. [21]:
Encapsulation efficiency (%) ¼ (Wtotal–Wfree) x 100/Wtotal (1)
Loading capacity (%) ¼ (Wtotal–Wfree) x 100/Wnp (2)
Where Wtotal was the total weight of flavonoids in liposome suspension
(mg), Wfree was the weight of free flavonoids in liposome suspension
(mg), and Wnp represented the liposome weight (mg).
3. Results and discussion
3.1. Morphology
The suspensions of free liposomes (FL) and PEL were freeze-dried
before observation under SEM to examine these samples' morphology
in solid-state. The microscopy images of nanosized liposomes with an
almost spherical shape are presented in Figure 1. The particles were well-
distributed with homogenous size. These images prove that both lipo-
somes were successfully isolated. From these images, the particle surface
of FL appears smoother than PEL, due to the propolis extract incorporated
at the outer surface of the liposomes.
The UV-Vis spectrum of studied propolis extract presented an intense
absorption band at 280 nm (Figure 2.). This absorption band wasFigure 2. UV-Vis spectra of free propolis extract, free liposomes and propolis
extract-loaded liposomes.
3
attributed to the presence of an A-ring of flavonoids [22]. The FL spec-
trum displayed no apparent peak of absorption. A similar absorption peak
was observed after the encapsulation of extract, and it exhibited Ein-
stein's shift softly, due to the existence of other materials composed in the
suspension, confirming the entrapment of the propolis extract in the
liposomes.
The potential chemical interaction between propolis extract and li-
posomes was evidenced by the FTIR spectral data as in Figure 3. The
absorption at 3404 cm1 correspondents to hydroxyl groups (O–H), was
attributed to the presence of flavonoid and phenolic compounds in the
propolis extract [23, 24]. The bands at 2927 cm1 and 2864 cm1 were
corresponded to the symmetrical stretches of CH3 and asymmetrical
stretches of CH2, respectively. These absorptions bands were correlated -
or associated - with waxes residues of the methanolic extract [25]. The
absorptions bands at 1701 cm1 (C¼O), 1635 cm1 (C¼C), 1454 cm1
(aromatic C–H) and at 1377 cm1 (aromatic C–O), were associated with
the presence of flavonoids. The profile of infrared spectrum obtained for
the propolis extract studied, was similar to the previous data published
for propolis from other origins [26, 27].
Compared to PEL, the functional group of O–H found at 3323 cm1,
and C¼O stretching at 1735 cm1 became broader and almost vanished
after the addition of propolis extract. This phenomenon has shown that
propolis extract is entrapped within the liposome bilayer, possibly
through hydrophobic interactions and hydrogen bonding [28, 29]. The
propolis extract's trapping into the liposome phospholipid bilayer was
due to hydrophobic interactions between the aromatic rings of propolis






















Figure 4. Effect of Stingless bees' extract concentration and liposome formulation on the particle size of propolis extract-loaded liposomes. Soy phosphatidylcholi-




























Figure 5. Effect of Stingless bees' extract concentration and liposome formulation on the polydispersity index of propolis extract-loaded liposomes. Soy phosphati-

























Figure 6. Effect of extract concentration and liposome formulation on zeta potential of propolis extract-loaded liposomes. Soy phosphatidylcholine:cholesterol (6:1 w/
w) ¼ F1, (8:1 w/w) ¼ F2, (10:1 w/w) ¼ F3.
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Figure 7. Calibration curve of absorbance at 420 nm versus quercetin (mg/mL)
in methanol.
N.A. Ramli et al. Heliyon 7 (2021) e06649bonding also occurred between the phospholipid bilayer's polar head
groups and the propolis extract's flavonoids, making it possible to
introduce propolis extract on the liposomes' outer surface. This finding is
also related to the image of SEM depicting the rougher surface of PEL
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Figure 8. Effect of extract concentration and liposome formulation on encapsulatio
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Figure 9. Effect of extract concentration and liposome formulation on the loading ca
(6:1 w/w) ¼ F1, (8:1 w/w) ¼ F2, (10:1 w/w) ¼ F3.
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3.2. Effect of extract concentration and liposome formulation on PEL
In this study, three formulations were analyzed to evaluate the ratio
of phosphatidylcholine to cholesterol. Incorporating cholesterol as an
essential component in the lipid membrane is a well-established strategy
to impart better liposome stability. It also aims to increase the rigidity of
the phospholipid bilayer and control its permeability [30]. This approach
leads to higher vesicle integrity for the fluid formulation, thus will in-
crease the efficiency of liposomes on encapsulation [31].
An increasing trend of average particle size for all formulations was
observed after being encapsulated with increasing concentration of
stingless bees' extract (Figure 4). The figure demonstrates that size in-
creases as the concentration of the extract increased. An increasing
amount of hydrophobic propolis molecules entrapped in the phospho-
lipid bilayer gave rise to the liposome size, significantly for F1. A pre-
vious study reported the increase in particle size of liposomes loaded
with green tea extract, which is higher than the unloaded liposomes [18].
The maximum concentration of extract that could be incorporated was
3.0 mg/ml for all those formulations. The instability of liposome sus-
pension was observed when the concentration of the extract was added in
excess. Large particles' aggregation was formed right after the prepara-












pacity of propolis extract-loaded liposomes. Soy phosphatidylcholine:cholesterol
N.A. Ramli et al. Heliyon 7 (2021) e06649The most significant increment was in F1, with a vesicle size change
rate of 92%. The possible reason for this result might be due to the
loosening effect of the phospholipid membrane. A low amount of phos-
phatidylcholine in the formulation led to an increment in the bilayer's
permeability, resulting in the increment of particle size after loaded with
propolis extract. In general, nanocarriers should be controlled in the
small particle size range to prevent mononuclear phagocyte recognition
and clearance by the reticuloendothelial system [30]. According to Li
et al. (2016), liposomes with particle size of 100 nm–300 nm have
excellent potency to transport the bioactive agents between and into cell
membranes [32]. Conversely, particles larger than 500 nm are reported
to be more likely excreted before reaching the bloodstream [33]. Thus,
this formulation was discarded since it showed unfavorable character-
istics of nanocarrier in terms of particle size.
On the other hand, the size for F2 and F3 at the highest concentration
of the extract was slightly smaller than F1, with 275.9 nm and 255.8 nm,
respectively. Particles of small size ranges have a comparatively high cell
uptake with faster drug release and a longer half-life in the blood than
larger particles. It also recorded that the penetration of smaller sized
nanoparticles through the rat intestinal loop's submucosal layers was
more effective than the larger particles that were primarily localized in
the epithelial lining [34]. In this regard, F2 and F3 will be further
assessed.
The difference in the PDI index exerted by the formulations is rep-
resented in Figure 5. At the highest concentration of propolis extract, F1
displayed the highest PDI index of 0.65. It indicates a polydisperse par-
ticulate system due to large particle size liposomes, as mentioned above.
Any of the small-sized liposomes were partly attached to larger lipo-
somes, due to loosening effect of the liposome membrane, which was
prepared with lower phosphatidylcholine amount, resulting in a particle
size non-regularity. The smaller size of liposomes produced in the other
two formulations resulted in more excellent dispersion with a lower PDI
index. F3 displayed the lowest PDI index among others with 0.26, sug-
gesting that the most uniform liposomes scale was synthesized in the
formulation. The dispersion of liposome was reduced to a lower index
attributed to the tightly packed membrane with highest amount of
phosphatidylcholine, thus the agglomeration of particles was avoided.
On top of that, zeta potential was measured to dictate the pharma-
cokinetic profiles and the fate of liposome stability. According to
Figure 6, it can be observed that there was an inverse relation between
zeta potential and propolis extract concentration. As the concentration of
propolis extract increased, the zeta potential of all formulations reduced.
This impact on the pattern could be related to the molecular association
between the phospholipids and the entrapped propolis extract, which
altered the significant charge at the liposomes' outer surface. In addition,
the presence of propolis extract particles on the outer surface of lipo-
somes, as seen in the scanning electron microscopy images, could also
influence the calculation of zeta potential. However, all formulations
prepared had a high magnitude of zeta potential (>30 mV), which led to
a tremendous electrostatic repulsion between the particles, thus pre-
venting agglomeration between the particles [35].
Effectiveness in encapsulation is an ultimate issue in the case of
applying liposome as a nanocarrier. The calibration curve of quercetin in
methanol with R2 ¼ 0.997 was constructed (Figure 7) to calculate the
encapsulation efficiency and loading based on the total flavonoids con-
tent. Figure 8 presented below showed an increasing trend of encapsu-
lation efficiency for all formulations with the increasing propolis extract
concentration. This increasing trend was similar to the loading, as shown
in Figure 9. At maximum concentration of propolis extract, F1 and F2
presented significantly higher encapsulation efficiency and loading than
F3. The low encapsulation efficiency of F3 was probably attributed to the
small size of the particle and the compact composition of hydrophobic
molecules, including cholesterol in the liposomal structure. Limited
space in the phospholipid bilayer, cholesterol, and propolis extract tend
to compete to be aligned within the packing of the alkyl chain of the
phospholipid [31]. Bozzuto and Molinari [30] also mentioned the6
reduced size of liposomes, leading to reduced drug storage capacity.
These factors resulted in the reduction of encapsulation efficiency with
the increasing amount of phosphatidylcholine.
In comparison between the other two formulations, F1 presented a
slightly higher encapsulation efficiency and loading than F2. This is due
to the larger size of particles yielded by the formulation. Higher fluidity
of the phospholipid in F1 contributed to a greater propolis extract ca-
pacity loaded into the bilayer. However, the smaller size of liposomes is
more favorable compared to the larger particles, as discussed earlier.
Thus, to choose the best formulation for synthesizing propolis-extract
loaded liposomes, F2 was selected as the optimum formulation
compared to the others. It represented a small particle size, which was
275.9 nm, with high encapsulation efficiency and loading, 66.9% and
18.1%, respectively. Herein, a significant effect of the ratio of phospha-
tidylcholine to cholesterol, on the physicochemical characteristics and
encapsulation efficiency of a liposomal system was proven.
4. Conclusion
The encapsulation of stingless bees' propolis extract in liposomes was
proven to occur through intermolecular hydrogen bonding and hydro-
phobic interaction between phospholipid membrane and propolis
extract, as observed in FTIR analysis. Three formulations were prepared,
and the liposomes were able to incorporate propolis extract up to 3.0 mg/
mL with increasing encapsulation efficiency and loading capacity, as well
as the liposome size. At 3.0 mg/mL, F2 (8:1 w/w) presented high
encapsulation efficiency (66.9%) and loading capacity (18.1%) while
maintaining its small liposome size at 275.9 nm. This formulation is
considered the best among others since F1 (6:1 w/w) formed the largest
size of liposome (422.8 nm), which are likely to be excreted from the
body before reaching the bloodstream. Meanwhile, F3 (10:1 w/w)
showed the lowest encapsulation efficiency (38.7%) and loading capacity
(8.5%), which limits the transportation of beneficial active compound
into the body. Liposome encapsulation of propolis flavonoid synthesized
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